EMDURAYB Trademark

Trademark Overview


On Tuesday, August 3, 2021, a trademark application was filed for EMDURAYB with the United States Patent and Trademark Office. The USPTO has given the EMDURAYB trademark a serial number of 90863268. The federal status of this trademark filing is ABANDONED - EXPRESS AFTER PUB as of Friday, September 2, 2022. This trademark is owned by Pfizer Inc.. The EMDURAYB trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use; pharmaceutical preparations for the treatment of hemophilia
emdurayb

General Information


Serial Number90863268
Word MarkEMDURAYB
Filing DateTuesday, August 3, 2021
Status605 - ABANDONED - EXPRESS AFTER PUB
Status DateFriday, September 2, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 7, 2022

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use; pharmaceutical preparations for the treatment of hemophilia

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateFriday, September 2, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events


Event DateEvent Description
Friday, September 2, 2022ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION
Friday, September 2, 2022ABANDONMENT - AFTER PUBLICATION
Thursday, September 1, 2022TEAS EXPRESS ABANDONMENT RECEIVED
Tuesday, August 2, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 7, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 7, 2022PUBLISHED FOR OPPOSITION
Wednesday, May 18, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, May 2, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, May 2, 2022ASSIGNED TO EXAMINER
Wednesday, September 29, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, August 6, 2021NEW APPLICATION ENTERED IN TRAM